Dyne Therapeutics, Inc.
DYN
44 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jun 30 11:05 PM | Jason P RhodesDirector | Sale | 195,427 | $21.14 | $4.1M | 975,931(I) | View → |
| Jun 26, 2026 | Jun 30 11:05 PM | Jason P RhodesDirector | Sale | 309,268 | $21.28 | $6.6M | 1,016,633(I) | View → |
| Jun 29, 2026 | Jun 29 9:50 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 51,756 | $20.94 | $1.1M | — | View → |
| Jun 29, 2026 | Jun 29 9:50 PM | Atlas Venture Fund XI, LP | Proposed Sale | 102,969 | $20.94 | $2.2M | — | View → |
| Jun 29, 2026 | Jun 29 9:49 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 40,702 | $20.94 | $852.3K | — | View → |
| Jun 26, 2026 | Jun 26 9:04 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 81,903 | $20.61 | $1.7M | — | View → |
| Jun 26, 2026 | Jun 26 9:04 PM | Atlas Venture Fund XI, LP | Proposed Sale | 162,954 | $20.61 | $3.4M | — | View → |
| Jun 26, 2026 | Jun 26 9:04 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 64,411 | $20.61 | $1.3M | — | View → |
| Jun 25, 2026 | Jun 26 8:15 PM | Erick LuceraChief Financial Officer | Sale | 2,362 | $20.37 | $48.1K | 121,563(D) | View → |
| Jun 25, 2026 | Jun 26 12:40 PM | Jason P RhodesDirector | Sale | 24,100 | $21.10 | $508.5K | 1,081,044(I) | View → |
| Jun 24, 2026 | Jun 26 12:40 PM | Jason P RhodesDirector | Sale | 95,900 | $21.02 | $2.0M | 1,086,063(I) | View → |
| Jun 23, 2026 | Jun 26 12:40 PM | Jason P RhodesDirector | Sale | 147,760 | $21.13 | $3.1M | 1,106,036(I) | View → |
| Jun 25, 2026 | Jun 25 9:29 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 6,382 | $20.33 | $129.7K | — | View → |
| Jun 25, 2026 | Jun 25 9:29 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 5,019 | $20.33 | $102.0K | — | View → |
| Jun 25, 2026 | Jun 25 9:28 PM | Atlas Venture Fund XI, LP | Proposed Sale | 12,699 | $20.33 | $258.2K | — | View → |
| Jun 25, 2026 | Jun 25 9:11 PM | Lucera Erick | Proposed Sale | 2,362 | $20.37 | $48.1K | — | View → |
| Jun 24, 2026 | Jun 24 9:36 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 25,397 | $20.26 | $514.5K | — | View → |
| Jun 24, 2026 | Jun 24 9:33 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 19,973 | $20.26 | $404.7K | — | View → |
| Jun 24, 2026 | Jun 24 9:32 PM | Atlas Venture Fund XI, LP | Proposed Sale | 50,530 | $20.26 | $1.0M | — | View → |
| Jun 23, 2026 | Jun 24 8:27 PM | Dirk KerstenDirector | Sale | 73,286 | $21.05 | $1.5M | 3,848,256(I) | View → |
Page 1 of 8
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Jun 23 8:07 PM | Barry E GreeneDirector | Grant/Award | 57,463 | $20.87 | 57,463(D) | View → |
| Jun 5, 2026 | Jun 9 9:15 PM | Edward HurwitzDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:13 PM | David Charles LubnerDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:13 PM | Jason P RhodesDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:12 PM | Dirk KerstenDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:12 PM | Carlo IncertiDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:09 PM | Catherine Stehman-BreenDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:06 PM | Brian S PosnerDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Feb 12, 2026 | Feb 17 10:11 PM | John CoxDirector, CEO & President | Grant/Award | 285,000 | $16.00 | 285,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:10 PM | Douglas KerrChief Medical Officer | Grant/Award | 130,000 | $16.00 | 130,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:09 PM | Johanna Friedl-NadererChief Commercial Officer | Grant/Award | 90,000 | $16.00 | 90,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:08 PM | Erick LuceraChief Financial Officer | Grant/Award | 105,000 | $16.00 | 105,000(D) | View → |